Fever, cough, and shortness of breath are the classic signs of COVID-19; however, there may be gastrointestinal signs, comparable to nausea and diarrhea, that are getting missed, in accordance with a new Stanford Medicine study.
Researchers discovered that, in addition to higher respiratory signs, a major number of these sick with the new virus suffered from lack of appetite, nausea, vomiting, and diarrhea.
The research, one of the earliest on U.S. sufferers with the coronavirus, was featured online on April 10 in Gastroenterology. Gastroenterology fellows George Cholankeril, MD, and Alexander Podboy, MD, share lead authorship. Aijaz Ahmed, MD, professor of gastroenterology and hepatology, is the senior writer.
As the coronavirus pandemic reach the San Francisco Bay Area in early March, hospitals began canceling elective surgeries and suspending nonemergency patient visits to make room for a surge of coronavirus sufferers. With their clinics shut and other initiatives on hold, a bunch of gastroenterology fellows had time to work together on a project, Podboy stated.
The researchers had been aware of a rising body of research out of China and Singapore that showed a prevalence of GI signs in COVID-19 sufferers but may find no data on the topic from sufferers in the U.S. They decided to conduct their own research by examining the charts of the earliest group of sufferers treated for the virus at Stanford Health Care.